Sreeven Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 3.69 Cr
as on 15-11-2024
- Company Age 32 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 15-11-2024
- Satisfied Charges ₹ 9.06 Cr
as on 15-11-2024
- Revenue -98.86%
(FY 2023)
- Profit -20.61%
(FY 2023)
- Ebitda -121.80%
(FY 2023)
- Net Worth -1143.23%
(FY 2023)
- Total Assets -20.67%
(FY 2023)
About Sreeven Pharma
The Corporate was formerly known as Richie Investments & Consultants Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.69 Cr.
The company currently has active open charges totaling ₹6.00 Cr. The company has closed loans amounting to ₹9.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Devendrappa Jegashetty and Sandeep Gokaraju serve as directors at the Company.
- CIN/LLPIN
U65993TG1992PTC014481
- Company No.
014481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1992
- Date of AGM
22 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sreeven Pharma Private Limited offer?
Sreeven Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Anti Acne Drug, Brain & Nervous System Drugs, Immunomodulator Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Smoking Drugs, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Steroid.
Who are the key members and board of directors at Sreeven Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendrappa Jegashetty  | Managing Director | 11-Apr-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Gokaraju | Director | 15-Jul-2022 | Current |
Financial Performance of Sreeven Pharma.
Sreeven Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 98.86% decrease. The company also saw a substantial fall in profitability, with a 20.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1143.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreeven Pharma?
In 2023, Sreeven Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bidar Pharma Testing Research And Development FoundationActive 10 months 17 daysDevendrappa Jegashetty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Aug 2024 | ₹6.00 Cr | Open |
Syndicate Bank Creation Date: 27 Jan 2017 | ₹1.20 Cr | Satisfied |
Canara Bank Creation Date: 22 Feb 2016 | ₹4.95 Cr | Satisfied |
How Many Employees Work at Sreeven Pharma?
Unlock and access historical data on people associated with Sreeven Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreeven Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreeven Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
